Catherine Grassman - 28 Feb 2022 Form 4 Insider Report for HESKA CORP

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
14 Jun 2023, 18:27:30 UTC
Prior SEC filing
09 Aug 2021
Next SEC filing
09 Mar 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Catherine Grassman

Key filing fact

Catherine Grassman filed Form 4 for HESKA CORP on 14 Jun 2023.

Key facts

  • This page summarizes Catherine Grassman's Form 4 filing for HESKA CORP.
  • 11 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 14 Jun 2023, 18:27.

Change

  • Previous filing in this sequence was filed on 09 Aug 2021.
  • Current net transaction value: -$6,802,080.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HSKA transaction

Common Stock

Award

Transaction value
$0
Shares
+38,096
Change %
+267%
Price
$0.000000
Shares after
52,357
Date
13 Jun 2023
Ownership
Direct
Footnotes
F1
HSKA transaction

Common Stock

Award

Transaction value
$0
Shares
+4,327
Change %
+8.3%
Price
$0.000000
Shares after
56,684
Date
13 Jun 2023
Ownership
Direct
Footnotes
F2
HSKA transaction

Common Stock

Disposed to Issuer

Transaction value
$6,802,080
Shares
-56,684
Change %
-100%
Price
$120.00
Shares after
0
Date
13 Jun 2023
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HSKA transaction Derivative

Non-Qualified Stock Option (right to buy)

Award

Transaction value
$0
Shares
+11,250
Change %
Price
$0.000000
Shares after
11,250
Date
28 Feb 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,250
Exercise price
$60.94
Footnotes
F4
HSKA transaction Derivative

Non-Qualified Stock Option (right to buy)

Award

Transaction value
$0
Shares
+23,750
Change %
+211%
Price
$0.000000
Shares after
35,000
Date
13 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
23,750
Exercise price
$60.94
Footnotes
F5
HSKA transaction Derivative

Non-Qualified Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares
-35,000
Change %
-100%
Price
Shares after
0
Date
13 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
35,000
Exercise price
$60.94
Footnotes
F4, F5, F6
HSKA transaction Derivative

Incentive Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares
-1,640
Change %
-100%
Price
Shares after
0
Date
13 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,640
Exercise price
$60.94
Footnotes
F6, F7
HSKA transaction Derivative

Non-Qualified Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares
-8,360
Change %
-100%
Price
Shares after
0
Date
13 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,360
Exercise price
$60.94
Footnotes
F6, F7
HSKA transaction Derivative

Non-Qualified Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares
-10,000
Change %
-100%
Price
Shares after
0
Date
13 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Exercise price
$70.10
Footnotes
F6, F8
HSKA transaction Derivative

Incentive Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares
-4,299
Change %
-100%
Price
Shares after
0
Date
13 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,299
Exercise price
$69.77
Footnotes
F6, F9
HSKA transaction Derivative

Non-Qualified Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares
-701
Change %
-100%
Price
Shares after
0
Date
13 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
701
Exercise price
$69.77
Footnotes
F6, F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Catherine Grassman is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 9 footnotes

Footnote F1

Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 31, 2023, by and among the Issuer, Antech Diagnostics, Inc., a California corporation ("Acquiror"), Helsinki Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Acquiror, and, solely for purposes of Section 9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation, these shares of performance-based restricted stock of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger.

Footnote F2

Pursuant to the Merger Agreement, these performance-based restricted stock units were fully accelerated assuming target level of performance immediately prior to the effectiveness of the merger.

Footnote F3

Disposed of pursuant to the Merger Agreement in exchange for cash consideration of $120.00 per share of common stock of the Issuer (the "Merger Consideration") on the effective date of the merger.

Footnote F4

Stock options of the Issuer became vested and exercisable upon achieving performance vesting conditions on February 28, 2022.

Footnote F5

Pursuant to the Merger Agreement, these stock options of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger.

Footnote F6

Stock options of the Issuer were canceled in the merger in exchange for an amount in cash equal to the difference, if any, between the Merger Consideration and the exercise price of such stock options.

Footnote F7

These stock options of the Issuer vested in two equal installments on December 31, 2021 and on December 31, 2022.

Footnote F8

These stock options of the Issuer vested as to two-thirds on June 1, 2020 and one-third on March 7, 2021.

Footnote F9

These stock options of the Issuer vested in three approximately equal annual installments beginning on March 7, 2019 and ending on March 7, 2021.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .